Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003

被引:99
作者
Tuffnell, DJ
Jankowicz, D
Lindow, SW
Lyons, G
Mason, GC
Russell, IF
Walker, JJ
机构
[1] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England
[2] Hull Hosp, Kingston Upon Hull, N Humberside, England
[3] E Yorkshire Hosp, Kingston Upon Hull, Yorks, England
[4] Leeds Teaching Hosp, Leeds, W Yorkshire, England
关键词
D O I
10.1111/j.1471-0528.2005.00565.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To establish the risk of serious complications from severe pre-eclampsia and eclampsia in a region using a common guideline for the management of these conditions. Design A five-year prospective study. Setting Sixteen maternity units in Yorkshire. Population All women managed with severe pre-eclampsia and eclampsia. Methods A common guideline was developed for the management of women with these conditions. A network of midwives prospectively collected outcome data. Main outcome measure Incidence of the conditions and serious complication rates. Results A total of 210,631 women delivered in the 16 units between 1 January 1999 and 31 December 2003. One thousand eighty-seven women were diagnosed with severe pre-eclampsia or eclampsia (5.2/1000). One hundred and fifty-one women had serious complications including 82 women (39/10,000) having eclamptic seizures and 49 women (23/10,000) requiring ICU admission. There were no maternal deaths but 54 out of 1145 babies died before discharge, giving a mortality rate of 47.2/1000. Of the 82 cases of eclampsia, 45 occurred antenatally (55%), 18 before admission to the maternity unit. Eleven cases occurred in labour (13%), including 1 during a caesarean section, and 26 cases occurred following delivery (32%). Twenty-five women developed pulmonary oedema (2.3% of cases) and six women required renal dialysis (0.55% of cases). One hundred and sixty-five (15%) required no antihypertensive therapy and 489 (53%) of the remainder required only oral therapy. Two hundred and one (18.5%) required more than one drug. Conclusion A regional guideline for severe pre-eclampsia and eclampsia can be developed and implemented. Its use may contribute to a low rate of serious complications.
引用
收藏
页码:875 / 880
页数:6
相关论文
共 19 条
[1]   Lack of agreement between central venous pressure and pulmonary capillary wedge pressure in preeclampsia [J].
Bolte, AC ;
Dekker, GA ;
van Eyck, J ;
van Schijndel, RS ;
van Geijn, HP .
HYPERTENSION IN PREGNANCY, 2000, 19 (03) :261-271
[2]  
*DEP HLTH WO, 1999, WHY MOTH DIE REP CON
[3]  
*DEP HLTH WO, 2001, WHY MOTH DIE REP CON
[4]   ECLAMPSIA IN THE UNITED-KINGDOM - THE BEST WAY FORWARD [J].
DOUGLAS, KA ;
REDMAN, CWG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (05) :355-356
[5]   ECLAMPSIA IN THE UNITED-KINGDOM [J].
DOUGLAS, KA ;
REDMAN, CWG .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6966) :1395-1400
[6]   Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit [J].
Drakeley, AJ ;
Le Roux, PA ;
Anthony, J ;
Penny, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (02) :253-256
[7]  
DULEY L, 1995, LANCET, V345, P1455
[8]   Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial [J].
Duley, L ;
Farrell, B ;
Spark, P ;
Roberts, B ;
Watkins, K ;
Bricker, L ;
Wang, L ;
Armstrong, N ;
Tivnin, M ;
Salih, N ;
Hurst, A ;
Smyth, R ;
Cooper, S ;
Wilson, A ;
Bowler, U ;
Notman, J .
LANCET, 2002, 359 (9321) :1877-1890
[9]  
Duley L, 2000, COCHRANE DB SYST REV
[10]  
Gilson G J, 1998, J Matern Fetal Med, V7, P142